Evidence map›Paper›PMID 34704394›Full record

ArticleVeterinary medicine and science2022

Detection of SARS-CoV-2 in two cats during the second wave of the COVID-19 pandemic in France.

Matthieu Fritz, Nicolas Nesi, Solène Denolly, Bertrand Boson, Vincent Legros, Serge G Rosolen, Alexandra Briend-Marchal, Meriadeg Ar Gouilh, Eric M Leroy

Open access · goldAbstract read
In one paragraph

Article in Veterinary medicine and science, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.8field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Matthieu FritzMaladies Infectieuses et Vecteurs: Ecologie, Génétique, Evolution et Contrôle (MIVEGEC), Université de Montpellier, IRD 224 - CNRS 5290, Institut de Recherche pour le Développement (IRD), Montpellier, France.ORCID 0000-0003-4112-3755
Nicolas NesiGroupe de Recherche sur l'Adaptation Microbienne (GRAM 2.0), Normandie Université, UNICAEN, UNIROUEN, EA2656, Caen, France.
Solène DenollyCIRI - Centre International de Recherche en Infectiologie, Team EVIR, Univ Lyon, Université Claude Bernard Lyon 1, Inserm, U111, CNRS, UMR5308, ENS Lyon, Lyon, France.
Bertrand BosonCIRI - Centre International de Recherche en Infectiologie, Team EVIR, Univ Lyon, Université Claude Bernard Lyon 1, Inserm, U111, CNRS, UMR5308, ENS Lyon, Lyon, France.
Vincent LegrosCIRI - Centre International de Recherche en Infectiologie, Team EVIR, Univ Lyon, Université Claude Bernard Lyon 1, Inserm, U111, CNRS, UMR5308, ENS Lyon, Lyon, France.
Serge G RosolenSorbonne Université, INSERM, CNRS, Institut de la Vision, Paris, France.
Alexandra Briend-MarchalLaboratoire de Biologie vétérinaire VEBIO, Arcueil, France.
Meriadeg Ar GouilhGroupe de Recherche sur l'Adaptation Microbienne (GRAM 2.0), Normandie Université, UNICAEN, UNIROUEN, EA2656, Caen, France.ORCID 0000-0002-3672-9974
Eric M LeroyMaladies Infectieuses et Vecteurs: Ecologie, Génétique, Evolution et Contrôle (MIVEGEC), Université de Montpellier, IRD 224 - CNRS 5290, Institut de Recherche pour le Développement (IRD), Montpellier, France.
Centre National de la Recherche Scientifique · FRUniversité Claude Bernard Lyon 1 · FRNormandie Université · FRCentre Hospitalier Vétérinaire Frégis · FR

Funding

French National Agency for Research : ANR-RA-COVID-19 (Geographical and temporal serological investigation of companion animal infection with SARS-CoV-2 during the second wave of COVID-19 in France, CoVet)IDEXLYON project of Université de Lyon as part of the "Programme Investissements d'Avenir" ANR-16-IDEX-0005OIE through the European Union EBO-SURSY projectWHO throught the SARS-CoV-2 EvoZoone project
6 · The paper itself

Abstract

Although there are several reports in the literature of SARS-CoV-2 infection in cats, few SARS-CoV-2 sequences from infected cats have been published. In this study, SARS-CoV-2 infection was evaluated in two cats by clinical observation, molecular biology (qPCR and NGS), and serology (microsphere immunoassay and seroneutralization). Following the observation of symptomatic SARS-CoV-2 infection in two cats, infection status was confirmed by RT-qPCR and, in one cat, serological analysis for antibodies against N-protein and S-protein, as well as neutralizing antibodies. Comparative analysis of five SARS-CoV-2 sequence fragments obtained from one of the cats showed that this infection was not with one of the three recently emerged variants of SARS-CoV-2. This study provides additional information on the clinical, molecular, and serological aspects of SARS-CoV-2 infection in cats.

Indexed as

Cat DiseasesCOVID-19AnimalsCatsFrancePandemicsSARS-CoV-2catsmild-respiratory clinical signsNGSOne HealthSARS-CoV-2serology

Identifiers

PMID34704394
PMCPMC8661769
OpenAlexW3208919460

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.